Company profile & Management

Sensible Medical Innovations is the market leader in medical radar (ReDS) monitoring and imaging technology. ReDS™ was adapted for medical use from military ‘see-through-wall’ technology. The technology is well-positioned to be a game changer in a wide range of applications and to become the next-generation lung fluid monitoring modality.

Vision – Striving to lead a new
Standard of Care in Heart Failure

ReDS™ enables the noninvasive monitoring and management of patients with fluid management problems. Lung fluid levels matter in the treatment of Heart Failure patients, and ReDS™ is designed with the needs of these patients in mind.

Sensible Medical is striving to lead the way toward a new standard of care for Heart Failure (HF), by giving healthcare professionals and patients a credible tool in the measurement of lung fluid, inside and outside the clinic setting.

Mission – To Empower Heart Failure
Professionals and Patients

Through ReDS™, Sensible Medical empowers Heart Failure professionals and patients by providing accurate, actionable, and absolute lung fluid measurements across the continuum of care. Our groundbreaking ReDS™ technology monitors the patient’s lung fluid status and serves as a decision support tool for physicians, providing them with valuable information in determining the right course of treatment. ReDS™ opens the possibility for physicians to deliver adequate treatment while their patients are still in an asymptomatic stage of fluid accumulation, which, when combined with other treatments, may help prevent symptoms that could lead to harmful Heart Failure deterioration in the future.

Management team

Amir Ronen,

CEO

Tzvia Broida,

CFO

Dr. Aharon (Ronnie) Abbo, MD,

CMO

Amir Ronen, CEO

Amir Ronen co-founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care.
Prior to founding Sensible Medical, he served as the vice president in two NASDAQ traded companies (NSDQ: FLSH, SFUN) and played a leading role in the strategy planning at Intel Corporation (NSDQ: INTC).
Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Tzvia Broida, CFO

Tzvia Broida joined Sensible Medical in 2011 as Chief Financial Officer. Prior to joining Sensible Medical, Tzvia Broida served as a member of the executive team of Jacada, (NASDAQ: JCDA). From 1995 to 2009, Ms. Broida worked at Jacada in executive finance roles of increasing responsibility.  Most recently, Ms. Broida served as the CFO for Jacada.  In her role as CFO, Ms. Broida took an active role in the company’s strategic processes, managed and participated in numerous M&A and Due Diligence processes, and led the organization’s Corporate Accounting, Finance, and Investor Relations functions. Prior to Jacada, Ms. Broida worked as an accountant at the accounting firm of Yehuda Ehrlich & Partners and at the accounting firm of Vexler, Kodenzick & Partners. Ms. Broida holds a B.A. in Accounting and Economics, from the Hebrew University of Jerusalem and is a CPA and member of the Israeli Society of Certified Public Accountants.

Dr. Aharon (Ronnie) Abbo, MD, CMO

Dr. Aharon (Ronnie) Abbo, an internal medicine physician, joined Sensible Medical in 2013 as VP, Clinical Affairs, and has served as Chief Medical Officer since January 2016.  Prior to joining Sensible Medical, Dr. Abbo was the Product Director of CARTO systems at Biosense Webster, Inc., part of the Johnson & Johnson Family of Companies.

From 2004 to 2013, Dr. Abbo worked at Biosense Webster, Inc., in Israel, Europe and the US. He brings broad experience in clinical strategy development and execution in relation to new product development, pre-commercial evaluations, evidence generation and product launch. Prior to Biosense Webster, Dr. Abbo was a Clinical Manager with BSP and a Clinical Analyst with QBI.

Dr. Abbo obtained his Medical Degree from Ben-Gurion University, Negev in 1996 and an Internal Medicine specialty (summa cum laude) in 2002 from Tel-Aviv Sourasky Medical Center, Israel, with a year of training at the New York Presbyterian Hospital in Manhattan, NYC. Dr. Abbo also holds a Masters in Internal Medicine from the CME School Sackler Faculty of Medicine, Tel–Aviv University. He is an author of a textbook chapter and has various medical publications and patents.

Eran Kurman,

VP Sales and Marketing

Nahum Hai,

COO

Amir Saroka,

CTO

Eran Kurman, VP Sales & Marketing

Prior to joining Sensible Medical, Mr. Kurman was VP of Global Commercial Strategy at Labstyle Innovations – Dario Health (NSDQ: DRIO).

With over 15 years of medical device experience in senior corporate and strategic roles, Mr. Kurman has held marketing positions of increasing responsibility with companies such as Ethicon Inc., a Johnson and Johnson company (NYSE: JNJ), and Lumenis Ltd. (NSDQ: LMNS). As VP of Global Commercial Strategy with Labstyle Innovations, Mr. Kurman built and led the strategic commercial planning and execution of an innovative diabetes monitoring product.

Mr. Kurman holds a B.Med.Sc from the Ben-Gurion University and a M.A. in Business Administration from the University of Haifa. 

Nahum Hai, COO

Nahum Hai joined Sensible Medical in 2010 as Chief Operating Officer.  Prior to joining Sensible Medical, Mr. Hai led the departments of VAS Engineering, Service Development, and 3G Engineering at Cellcom, (NYSE:CEL), Israel’s largest cellular operator.

From 2001 to 2010, Mr. Hai worked at Cellcom in roles of increasing responsibility. Most recently, Mr. Hai served as the Department Manager of Advanced Services. At Cellcom, Mr. Hai led project/product management, system integrations and development, and managed the delivery of cross-organizational, complex customer projects that served over 1M active users and generated tens of millions of dollars in revenues. Mr. Hai managed SW development of content delivery platforms and internet applications, and was responsible for introducing new products from concept to support. He began his career in the Israel Defense Forces in 1995.

Mr. Hai holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, an M.A. in Business Administration from the Technion – Israel Institute of Technology, and an M.A. in Law with a specialization in Patent Law from Haifa University.

Amir Saroka, CTO

Amir Saroka co-founded Sensible Medical Innovations in 2007, and now serves as Chief Technology Officer. Prior to founding Sensible Medical, Mr. Saroka was the department manager of an elite R&D unit in the Israel Defense Forces.

From 1997 to 2005, Mr. Saroka headed projects for the Israeli Ministry of Defense in the areas of wireless and wired communication, software engineering, embedded software, signal processing, digital circuit design and more.

Mr. Saroka holds an M.Sc. in Electrical Engineering from Tel-Aviv University, and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Shlomi Bergida,

VP Product Management

Nadav Mizrahi,

VP R&D

Inbal Ben-Tzvi,

VP Regulatory Affairs

Shlomi Bergida, VP Product Management

Shlomi Bergida co-founded Sensible Medical in 2007, and now serves as VP of Product Management. Prior to founding Sensible Medical, Mr. Bergida held positions of increasing responsibility with an elite electronics R&D unit in the Israeli Ministry of Defense.

From 1998 to 2006, Mr. Bergida headed various large-scale projects of R&D activities for the Israeli Defense Forces, where he developed his areas of expertise in multidisciplinary system definition, design, and implementation.

Mr. Bergida holds an M.Sc. in Electrical Engineering from Tel-Aviv University in Israel and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Nadav Mizrahi, VP R&D

Nadav Mizrahi joined Sensible Medical in 2007, and now serves as VP of R&D. Prior to joining Sensible Medical, Mr. Mizrahi served at an elite electronics R&D unit in the Israeli Ministry of Defense.

From 1998 to 2006, Mr. Mizrahi led the research and development of various digital and analogue platforms designed to fit within high performance and reliable communication systems. During his time with the Israeli Defense Forces, Mr. Mizrahi developed deep expertise in system design, high performance digital hardware, micro-wave systems, ASIC and board level design, as well as R&D and QA team management.

Mr. Mizrahi holds a M.Sc. in Bio-Medical Engineering and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

 

Inbal Ben-Tzvi, VP Regulatory Affairs

Inbal Ben-Tzvi joined Sensible Medical in 2013 as VP of Regulatory Affairs.  Prior to joining Sensible Medical, Ms. Ben-Tzvi was VP of Clinical and Regulatory Affairs for Medingo Roche.

From 1998 to 2013, Ms. Ben-Tzvi held regulatory positions of increasing responsibility for Israeli and US companies, including BioPreventive, Medingo Roche, UltraShape, and Technical Resources International, Inc.  She has fulfilled different regulatory, clinical and quality assurance responsibilities, overseeing IVDs, medical devices, drugs and biologics products throughout the product development lifecycle. Her experience includes addressing the requirements of regulatory authorities in over 20 different countries.

Ms. Ben-Tvzi holds a Master of Science degree from the Weizmann Institute of Science and holds the RAPS Regulatory Affairs Certificate (RAC).

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Amir Ronen, CEO

Amir Ronen founded Sensible Medical Innovations in 2007 with the aim of bringing top notch technology innovations to the area of heart failure care. Prior to founding Sensible Medical, he held executive positions at leading global companies, including M-Systems, Intel, and Saifun. In his previous role as VP of Marketing & Business Development at M-Systems (previously NSDQ:FLSH), Mr. Ronen initiated the breakthrough ‘X4 technology’ that revolutionized the flash memory market. Prior to that, at Intel Corp (NSDQ: INTC), he led Intel’s flagship paradigm shift microprocessor.

Amir holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, and an MBA from the Kellogg (Northwestern University)-Recanati (Tel-Aviv University) International Executive MBA program.

Tzvia Broida, CFO

Tzvia Broida joined Sensible Medical in 2011 as Chief Financial Officer. Prior to joining Sensible Medical, Tzvia Broida served as a member of the executive team of Jacada, (NASDAQ: JCDA). From 1995 to 2009, Ms. Broida worked at Jacada in executive finance roles of increasing responsibility.  Most recently, Ms. Broida served as the CFO for Jacada.  In her role as CFO, Ms. Broida took an active role in the company’s strategic processes, managed and participated in numerous M&A and Due Diligence processes, and led the organization’s Corporate Accounting, Finance, and Investor Relations functions. Prior to Jacada, Ms. Broida worked as an accountant at the accounting firm of Yehuda Ehrlich & Partners and at the accounting firm of Vexler, Kodenzick & Partners. Ms. Broida holds a B.A. in Accounting and Economics, from the Hebrew University of Jerusalem and is a CPA and member of the Israeli Society of Certified Public Accountants.

Dr. Aharon (Ronnie) Abbo, MD, CMO

Dr. Aharon (Ronnie) Abbo, an internal medicine physician, joined Sensible Medical in 2013 as VP, Clinical Affairs, and has served as Chief Medical Officer since January 2016.  Prior to joining Sensible Medical, Dr. Abbo was the Product Director of CARTO systems at Biosense Webster, Inc., part of the Johnson & Johnson Family of Companies.

From 2004 to 2013, Dr. Abbo worked at Biosense Webster, Inc., in Israel, Europe and the US. He brings broad experience in clinical strategy development and execution in relation to new product development, pre-commercial evaluations, evidence generation and product launch. Prior to Biosense Webster, Dr. Abbo was a Clinical Manager with BSP and a Clinical Analyst with QBI.

Dr. Abbo obtained his Medical Degree from Ben-Gurion University, Negev in 1996 and an Internal Medicine specialty (summa cum laude) in 2002 from Tel-Aviv Sourasky Medical Center, Israel, with a year of training at the New York Presbyterian Hospital in Manhattan, NYC. Dr. Abbo also holds a Masters in Internal Medicine from the CME School Sackler Faculty of Medicine, Tel–Aviv University. He is an author of a textbook chapter and has various medical publications and patents.

Eran Kurman, VP Sales & Marketing

Eran Kurman joined Sensible Medical in October 2015 as VP of Sales and Marketing.  Prior to joining Sensible Medical, Mr. Kurman was VP of Global Commercial Strategy at Labstyle Innovations.

From 2001 to 2015, Mr. Kurman held marketing positions of increasing responsibility with companies such as Ethicon Inc., a Johnson and Johnson company, and Lumenis Ltd. In his most recent role as VP Global Commercialization Strategy, Mr. Kurman built and led the strategic commercial planning and execution of an innovative diabetes monitoring product for LabStyle Innovations. Mr. Kurman began his career with QuintilesIMS as a CRA.

Mr. Kurman holds a B.Med.Sc from the Ben-Gurion University and a M.A. in Business Administration from the University of Haifa.

Nahum Hai, COO

Nahum Hai joined Sensible Medical in 2010 as Chief Operating Officer.  Prior to joining Sensible Medical, Mr. Hai led the departments of VAS Engineering, Service Development, and 3G Engineering at Cellcom, (NYSE:CEL), Israel’s largest cellular operator. From 2001 to 2010, Mr. Hai worked at Cellcom in roles of increasing responsibility. Most recently, Mr. Hai served as the Department Manager of Advanced Services. At Cellcom, Mr. Hai led project/product management, system integrations and development, and managed the delivery of cross-organizational, complex customer projects that served over 1M active users and generated tens of millions of dollars in revenues. Mr. Hai managed SW development of content delivery platforms and internet applications, and was responsible for introducing new products from concept to support. He began his career in the Israel Defense Forces in 1995. Mr. Hai holds a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology, an M.A. in Business Administration from the Technion – Israel Institute of Technology, and an M.A. in Law with a specialization in Patent Law from Haifa University.

Amir Saroka, CTO

Amir Saroka co-founded Sensible Medical Innovations in 2007, and now serves as Chief Technology Officer. Prior to founding Sensible Medical, Mr. Saroka was the department manager of an elite R&D unit in the Israel Defense Forces. From 1997 to 2005, Mr. Saroka headed projects for the Israeli Ministry of Defense in the areas of wireless and wired communication, software engineering, embedded software, signal processing, digital circuit design and more. Mr. Saroka holds an M.Sc. in Electrical Engineering from Tel-Aviv University, and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Gal Meister, Chief Development Officer

Gal Meister joined Sensible Medical in October 2015 as Chief Development Officer.  Prior to joining Sensible Medical, Mr. Meister served as VP of R&D and Operations at AngioSlide, Ltd.

From 2008 to 2015, Mr. Meister worked at AngioSlide, Ltd., where he played a major role in the development and manufacturing of multiple medical devices. Prior to AnglioSlide, Mr. Meister was a project manager/system engineer for the Israeli Air Force.

Mr. Meister holds an M.B.A. from the University of Tel Aviv, an M.Sc. degree in Electrical Engineering from the University of Tel Aviv, and another degree in Mechanical Engineering from the University of Tel Aviv.

Shlomi Bergida, VP Product Management

Shlomi Bergida co-founded Sensible Medical in 2007, and now serves as VP of Product Management. Prior to founding Sensible Medical, Mr. Bergida held positions of increasing responsibility with an elite electronics R&D unit in the Israeli Ministry of Defense.

From 1998 to 2006, Mr. Bergida headed various large-scale projects of R&D activities for the Israeli Defense Forces, where he developed his areas of expertise in multidisciplinary system definition, design, and implementation.

Mr. Bergida holds an M.Sc. in Electrical Engineering from Tel-Aviv University in Israel and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

Nadav Mizrahi, VP R&D

Nadav Mizrahi joined Sensible Medical in 2007, and now serves as VP of R&D. Prior to joining Sensible Medical, Mr. Mizrahi served at an elite electronics R&D unit in the Israeli Ministry of Defense.

From 1998 to 2006, Mr. Mizrahi led the research and development of various digital and analogue platforms designed to fit within high performance and reliable communication systems. During his time with the Israeli Defense Forces, Mr. Mizrahi developed deep expertise in system design, high performance digital hardware, micro-wave systems, ASIC and board level design, as well as R&D and QA team management.

Mr. Mizrahi holds a M.Sc. in Bio-Medical Engineering and a B.Sc. in Electrical Engineering from the Technion – Israel Institute of Technology.

 

Inbal Ben-Tzvi, VP Regulatory Affairs

Inbal Ben-Tzvi joined Sensible Medical in 2013 as VP of Regulatory Affairs.  Prior to joining Sensible Medical, Ms. Ben-Tzvi was VP of Clinical and Regulatory Affairs for Medingo Roche.

From 1998 to 2013, Ms. Ben-Tzvi held regulatory positions of increasing responsibility for Israeli and US companies, including BioPreventive, Medingo Roche, UltraShape, and Technical Resources International, Inc.  She has fulfilled different regulatory, clinical and quality assurance responsibilities, overseeing IVDs, medical devices, drugs and biologics products throughout the product development lifecycle. Her experience includes addressing the requirements of regulatory authorities in over 20 different countries.

Ms. Ben-Tvzi holds a Master of Science degree from the Weizmann Institute of Science and holds the RAPS Regulatory Affairs Certificate (RAC).